We are live on ! Find out more
PAM

Panagora Asset Management Portfolio holdings

AUM $26.7B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+36.4%
3 Year Est. Return
+128.64%
5 Year Est. Return
+186.75%
10 Year Est. Return
+733.24%
AUM
$26.7B
AUM Growth
+$1.39B
Cap. Flow
-$23.1M
Cap. Flow %
-0.09%
Top 10 Hldgs %
17.97%
Holding
2,475
New
156
Increased
807
Reduced
895
Closed
166

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$46M
2
GILD icon
Gilead Sciences
GILD
+$45.6M
3
LLY icon
Eli Lilly
LLY
+$40.5M
4
CSCO icon
Cisco
CSCO
+$39.5M
5
HD icon
Home Depot
HD
+$37.5M

Sector Composition

Rank Sector Weight
1 Financials 17.3%
2 Technology 15.49%
3 Healthcare 13.62%
4 Consumer Discretionary 11.05%
5 Industrials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADMS
1876
DELISTED
Adamas Pharmaceuticals
ADMS
$99K ﹤0.01%
+2,930
New +$81.8K
CLUB
1877
DELISTED
Town Sports International Holdings, Inc.
CLUB
$99K ﹤0.01%
17,963
-332
-2% -$2.05K
NVS icon
1878
Novartis
NVS
$297B
$98K ﹤0.01%
1,305
CGNT
1879
DELISTED
Cogentix Medical, Inc.
CGNT
$98K ﹤0.01%
31,020
+3,019
+11% +$8.7K
KTEC
1880
DELISTED
Key Technology Inc
KTEC
$98K ﹤0.01%
5,295
+4,426
+509% +$79.2K
IART icon
1881
Integra LifeSciences
IART
$1.29B
$97K ﹤0.01%
2,030
MRC
1882
DELISTED
MRC Global
MRC
$97K ﹤0.01%
5,742
-33,376
-85% -$551K
STRL icon
1883
Sterling Infrastructure
STRL
$18.3B
$97K ﹤0.01%
5,953
-44,058
-88% -$726K
AIMT
1884
DELISTED
Aimmune Therapeutics
AIMT
$97K ﹤0.01%
+2,559
New +$82.6K
ZD icon
1885
Ziff Davis
ZD
$1.96B
$96K ﹤0.01%
1,466
WBT
1886
DELISTED
Welbilt, Inc.
WBT
$96K ﹤0.01%
4,066
ASRT
1887
DELISTED
Assertio
ASRT
$95K ﹤0.01%
196
LITS
1888
Lite Strategy Inc
LITS
$32.8M
$95K ﹤0.01%
2,269
-59
-3% -$2.77K
REX icon
1889
REX American Resources
REX
$1.42B
$95K ﹤0.01%
6,930
UE icon
1890
Urban Edge Properties
UE
$2.86B
$95K ﹤0.01%
3,724
-39,860
-91% -$991K
ISEE
1891
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$95K ﹤0.01%
+30,439
New +$85.6K
MDP
1892
DELISTED
Meredith Corporation
MDP
$95K ﹤0.01%
1,435
PRGX
1893
DELISTED
PRGX Global, Inc.
PRGX
$95K ﹤0.01%
13,398
-348
-3% -$2.53K
FNHC
1894
DELISTED
FedNat Holding Company Common Stock
FNHC
$94K ﹤0.01%
5,672
-71,213
-93% -$1.06M
ALLY icon
1895
Ally Financial
ALLY
$13.2B
$93K ﹤0.01%
3,200
-2,590
-45% -$68.7K
VRDN icon
1896
Viridian Therapeutics
VRDN
$2.09B
$93K ﹤0.01%
595
-16
-3% -$2.04K
INOV
1897
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$93K ﹤0.01%
6,200
FICO icon
1898
Fair Isaac
FICO
$24.3B
$92K ﹤0.01%
600
RDY icon
1899
Dr. Reddy's Laboratories
RDY
$9.87B
$92K ﹤0.01%
+12,310
New +$88.7K
AVP
1900
DELISTED
Avon Products, Inc.
AVP
$92K ﹤0.01%
42,820
-13,300
-24% -$28.6K

Similar funds

Panagora Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Panagora Asset Management held 2,475 positions worth $26.7B, up 5.5% from $25.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Panagora Asset Management's Q4 2017 filing shows 156 new, 807 increased, 895 reduced and 166 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 376,571 shares worth $19.8M. The largest sale was Pfizer, an estimated $46M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Panagora Asset Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 376,571 shares worth $19.8M.
  • Panagora Asset Management added most to iShares MSCI EAFE ETF in Q4 2017, an estimated $87.3M increase.
  • Panagora Asset Management's biggest Q4 2017 reduction was Pfizer, cutting an estimated $46M.
  • Panagora Asset Management fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $8.2M.
  • Panagora Asset Management's ten largest holdings make up 18% of its $26.7B portfolio in Q4 2017.
  • Panagora Asset Management opened 156 new positions and closed 166 in Q4 2017.
  • Panagora Asset Management's portfolio value rose 5.5% quarter-over-quarter to $26.7B.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.